University Hospitals:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:University Hospitals - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9294
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
University Hospitals is a healthcare service provider that offers patient-centered medical care and education services. The center’s services include abdominal imaging, acupuncture, addiction recovery, advanced heart failure and transplant, bariatric surgery, behavioral pediatrics and psychology. It also offers radiology, cancer services, plastic and reconstructive surgery, sports medicine, cardiac rehabilitation, cardiac surgery, gynecologic surgery, hand surgery, gynecologic cancer, interventional radiology, laboratory services, minimally invasive surgery, nutrition services, and others. University Hospitals’ radiology services include computerized tomography, magnetic resonance imaging, digital mammography and ultrasound. The hospital provides clinical research and medical education services. It serves throughout Northeast Ohio. University Hospitals is headquartered in Cleveland, Ohio, the US.

University Hospitals – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
University Hospitals, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Hospitals, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University Hospitals, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Hospitals, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University Hospitals, Medical Devices Deals, 2012 to YTD 2018 9
University Hospitals, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
University Hospitals, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
BioMotiv Raises US$25 Million In Venture Financing 11
BioMotiv Raises US$21 Million In Series A Financing 12
Partnerships 13
Moleculin Biotech Enters into Agreement with University Hospitals Cleveland Medical 13
Mercy Health System Enters Into Agreement With Seidman Cancer Center To Offer Cancer Treatment Services 14
Acquisition 15
University Hospitals Receives Approval From State And Federal Government Regulators To Acquire Parma Community General Hospital 15
University Hospitals To Acquire EMH Regional Medical Center 16
University Hospitals – Key Competitors 17
University Hospitals – Key Employees 18
University Hospitals – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
University Hospitals, Pharmaceuticals & Healthcare, Key Facts 2
University Hospitals, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Hospitals, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
University Hospitals, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Hospitals, Deals By Therapy Area, 2012 to YTD 2018 8
University Hospitals, Medical Devices Deals, 2012 to YTD 2018 9
University Hospitals, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
BioMotiv Raises US$25 Million In Venture Financing 11
BioMotiv Raises US$21 Million In Series A Financing 12
Moleculin Biotech Enters into Agreement with University Hospitals Cleveland Medical 13
Mercy Health System Enters Into Agreement With Seidman Cancer Center To Offer Cancer Treatment Services 14
University Hospitals Receives Approval From State And Federal Government Regulators To Acquire Parma Community General Hospital 15
University Hospitals To Acquire EMH Regional Medical Center 16
University Hospitals, Key Competitors 17
University Hospitals, Key Employees 18
University Hospitals, Subsidiaries 19

List of Figures
University Hospitals, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
University Hospitals, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
University Hospitals, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
University Hospitals, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
University Hospitals, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
University Hospitals, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
University Hospitals, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
University Hospitals, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
University Hospitals, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[University Hospitals:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Putnam Investments LLC:企業の戦略的SWOT分析
    Putnam Investments LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Baylor College of Medicine:企業のM&A・事業提携・投資動向
    Baylor College of Medicine - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Baylor College of Medicine Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Dot Foods, Inc.:企業の戦略・SWOT・財務情報
    Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dot Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lion Energy Ltd (LIO):石油・ガス:M&Aディール及び事業提携情報
    Summary Lion Energy Ltd (Lion) is an oil and gas company that explores, develops and produces unconventional oil and gas resources in Indonesia. The company has conventional production sharing contracts such as Seram project and South Block A project. Its Seram project is located on the island of Se …
  • Volkswagen AG (VOW3):企業の財務・戦略的SWOT分析
    Volkswagen AG (VOW3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yingli Green Energy Holding Company Limited (YGE):企業の財務・戦略的SWOT分析
    Yingli Green Energy Holding Company Limited (YGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Eurofins Scientific SE:企業の戦略・SWOT・財務情報
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Exact Imaging Inc:医療機器:M&Aディール及び事業提携情報
    Summary Exact Imaging Inc (Exact Imaging) formerly Imagistx Inc, is a provider of high-resolution micro-ultrasound systems enabling real-time imaging and guided biopsies for prostate cancer analysis. The company’s ExactVu micro-ultrasound platform operates high resolution conventional and biopsy tra …
  • Tristan Technologies Inc:企業の製品パイプライン分析
    Summary Tristan Technologies Inc (Tristan) is a medical device company that offers laboratory products. The company designs, develops and manufactures components and systems for biomagnetic measurement and clinical applications. Its products comprise biomagnetic devices, geomagnetic, cryogenic, non- …
  • Electricite de France SA (EDF):企業の財務・戦略的SWOT分析
    Electricite de France SA (EDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sumo Group PLC (SUMO):企業の財務・戦略的SWOT分析
    Sumo Group PLC (SUMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Glaukos Corp (GKOS):医療機器:M&Aディール及び事業提携情報
    Summary Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such …
  • Ricoh Imaging Co Ltd:企業の戦略的SWOT分析
    Ricoh Imaging Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Total E&P Canada Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Total E&P Canada Ltd (Total E&P Canada), a subsidiary of Total S.A. is an oil and gas company that offers exploration and production of oil and gas properties. The company has assets in Alberta’s Athabasca Oil Sands region, which include Surmont, Northern Lights, Fort Hills and Joslyn North …
  • InCarda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InCarda Therapeutics Inc (InCarda) is a biopharmaceutical company that concentrates on the development of transformative therapies for cardiovascular conditions through the inhalation route. The company’s lead product candidate includes InRhythm, an inhaled antiarrhythmic for acute treatment …
  • Stamford Land Corporation Ltd:企業の戦略・SWOT・財務情報
    Stamford Land Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Stamford Land Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BioLight Israeli Life Sciences Ltd (BOLT):医療機器:M&Aディール及び事業提携情報
    Summary BioLight Israeli Life Sciences Ltd (Bio-Light), formerly Bio Light Israeli Life Sciences Investments Ltd is an ophthalmic company that discovers, develops and commercializes products and product candidates for various ophthalmic conditions. The company invests in managing and commercializing …
  • UTC Engenharia SA:企業の戦略的SWOT分析
    UTC Engenharia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • HeartSine Technologies LLC:企業の戦略的SWOT分析
    HeartSine Technologies LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ricoh Company, Ltd. (7752):企業の財務・戦略的SWOT分析
    Ricoh Company, Ltd. (7752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆